Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 37: 430-434, 1991;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laureys, M.
Right arrow Articles by Gorus, F. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laureys, M.
Right arrow Articles by Gorus, F. K.

Clinical Chemistry, Vol 37, 430-434, Copyright © 1991 by American Association for Clinical Chemistry

Macromolecular creatine kinase type 1: a serum marker associated with disease

M Laureys, JP Sion, H Slabbynck, L Steenssens, C Cobbaert, MP Derde and FK Gorus
Department of Clinical Chemistry, Akademisch Ziekenhuis Vrije Universiteit Brussel, Belgium.

The prevalence of circulating macromolecular creatine kinase type 1 (macro CK type 1 or CK-immunoglobulin complexes) is significantly higher in a patient population selected for CK isoenzyme assay than in age- and sex-matched blood donors (n = 1304). In greater than 8000 patients studied, 49 individuals with macro CK type 1 were identified, yielding an overall prevalence of 0.61%. Macro CK type 1 complexes occurred more frequently in women and in patients older than 70 years, and were often associated with complications of cardiovascular disease, life-threatening conditions, and poor outcome. These latter clinical associations could arise, at least partly, from the selection of patients for whom CK isoenzyme analysis was ordered.


The following articles in journals at HighWire Press have cited this article:


Home page
 Br Med BullHome page
P. Brancaccio, N. Maffulli, and F. M. Limongelli
Creatine kinase monitoring in sport medicine
Br. Med. Bull., June 14, 2007; (2007) ldm014v1.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
B. Galarraga, D. Sinclair, M. N. Fahie-Wilson, F. C. McCrae, R. G. Hull, and J. M. Ledingham
A rare but important cause for a raised serum creatine kinase concentration: two case reports and a literature review
Rheumatology, January 1, 2003; 42(1): 186 - 188.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Association for Clinical Chemistry.